Investor Relations
Company Overview
Magenta Therapeutics is a clinical-stage biotechnology company developing medicines to bring the curative power of immune system reset through stem cell transplant to more patients with blood cancers, genetic diseases and autoimmune diseases. Magenta is combining leadership in stem cell biology and biotherapeutics development with clinical and regulatory expertise, a unique business model and broad networks in the stem cell transplant community to revolutionize immune reset for more patients.
USD
Data Provided by Refinitiv. Minimum 15 minutes delayed.
Media and Investor Contact
For investor and media inquiries, please click here